Literature DB >> 12225377

Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.

Graham R Leggatt1, Linda A Dunn, Rachel L De Kluyver, Trina Stewart, Ian H Frazer.   

Abstract

Keratinocytes expressing the human papillomavirus (HPV) type 16 E7 protein, as a transgene driven by the K14 promoter, form a murine model of HPV-mediated epithelial cancers in humans. Our previous studies have shown that K14E7 transgenic skin grafts onto syngeneic mice are not susceptible to immune destruction despite the demonstrated presence of a strong, systemic CTL response directed against the E7 protein. Consistent with this finding, we now show that cultured, E7 transgenic keratinocytes (KC) express comparable endogenous levels of E7 protein to a range of CTL-sensitive E7-expressing cell lines but are not susceptible to CTL-mediated lysis in vitro. E7 transgenic and non-transgenic KC are susceptible to conventional mechanisms of CTL-mediated lysis, including perforin and Fas/FasL interaction when an excess of exogenous peptide is provided. The concentration of exogenous peptide required to render a cell susceptible to lysis was similar between KC and other conventional CTL targets (e.g. EL-4), despite large differences in H-2Db expression at the cell surface. Furthermore, exposure of KC to IFN-gamma increased H-2Db expression, but did not substantially alter the exogenous peptide concentration required to sensitize cells for half maximal lysis. In contrast, the lytic sensitivity of transgenic KC expressing endogenous E7 is modestly improved by exposure to IFN-gamma. Thus, failure of CTL to eliminate KC expressing endogenous E7, and by inference squamous tumours expressing E7, may reflect the need for a sustained, local inflammatory environment during the immune effector phase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225377     DOI: 10.1046/j.1440-1711.2002.01105.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  8 in total

1.  Synthetic skin-permeable proteins enabling needleless immunization.

Authors:  Yongzhuo Huang; Yoon Shin Park; Cheol Moon; Allan E David; Hee Sun Chung; Victor C Yang
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-01       Impact factor: 15.336

2.  Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.

Authors:  Ki Su Kim; Hyemin Kim; Yunji Park; Won Ho Kong; Seung Woo Lee; Sheldon J J Kwok; Sei Kwang Hahn; Seok Hyun Yun
Journal:  Adv Funct Mater       Date:  2016-02-01       Impact factor: 18.808

3.  HPV16-E7-Specific Activated CD8 T Cells in E7 Transgenic Skin and Skin Grafts.

Authors:  Seyed Davoud Jazayeri; Paula T Kuo; Graham Robert Leggatt; Ian H Frazer
Journal:  Front Immunol       Date:  2017-05-04       Impact factor: 7.561

4.  Human papillomavirus E7 oncoprotein expression by keratinocytes alters the cytotoxic mechanisms used by CD8 T cells.

Authors:  Purnima Bhat; Anne-Sophie Bergot; Nigel Waterhouse; Ian Hector Frazer
Journal:  Oncotarget       Date:  2017-12-14

5.  Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.

Authors:  Paula Kuo; Siok Min Teoh; Zewen K Tuong; Graham R Leggatt; Stephen R Mattarollo; Ian H Frazer
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

6.  The kinematics of cytotoxic lymphocytes influence their ability to kill target cells.

Authors:  Purnima Bhat; Graham Leggatt; Klaus I Matthaei; Ian H Frazer
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

7.  Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity.

Authors:  Purnima Bhat; Graham Leggatt; Nigel Waterhouse; Ian H Frazer
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

8.  High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.

Authors:  Chloe Chong; Fabio Marino; HuiSong Pak; Julien Racle; Roy T Daniel; Markus Müller; David Gfeller; George Coukos; Michal Bassani-Sternberg
Journal:  Mol Cell Proteomics       Date:  2017-12-14       Impact factor: 5.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.